← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 14, 2021Last known activity
May 31, 2026
Timeline
No events for the selected filters.
Drugs by trial phase (20 distinct, 10 trials)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Recent trials (10)
- NCT07203053Lead sponsorPhase 2May 31, 2026
- NCT06931717Lead sponsorPhase 3Nov 30, 2025
- NCT06284317Lead sponsorPhase 3Dec 31, 2024
- NCT06068153Lead sponsorPhase 2Mar 31, 2024
- NCT05896566Lead sponsorPhase 2Dec 1, 2023
- NCT05718297Lead sponsorPhase 2Dec 1, 2023
- NCT05718323Lead sponsorPhase 2Dec 1, 2023
- NCT05673187Lead sponsorPhase 2Jun 12, 2023
- NCT05601973Lead sponsorPhase 2Feb 1, 2023
- NCT05063786CollaboratorPhase 3Sep 14, 2021
Details
- Last known activity
- May 31, 2026